Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FALCONE, Antonietta")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 15 of 15

  • Page / 1
Export

Selection :

  • and

Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: A phase II trialMARCHETTI, Monia; BAROSI, Giovanni; GROSSI, Alberto et al.Journal of clinical oncology. 2004, Vol 22, Num 3, pp 424-431, issn 0732-183X, 8 p.Article

Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromesMUSTO, Pellegrino; FALCONE, Antonietta; SANPAOLO, Grazia et al.Haematologica (Roma). 2002, Vol 87, Num 8, pp 884-886, issn 0390-6078Article

Combined therapy with amifostine plus erythropoietin for the treatment of myelodysplastic syndromesGROSSI, Alberto; MUSTO, Pellegrino; SANTINI, Valeria et al.Haematologica (Roma). 2002, Vol 87, Num 3, pp 322-323, issn 0390-6078Article

Inefficacy of clarithromycin in advanced multiple myeloma: a definitive reportMUSTO, Pellegrino; FALCONE, Antonietta; SANPAOLO, Grazia et al.Haematologica (Roma). 2002, Vol 87, Num 6, pp 658-659, issn 0390-6078Article

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patientsROCCI, Alberto; GAMBELLA, Manuela; ISAIA, Gianluca et al.British journal of haematology. 2014, Vol 164, Num 6, pp 841-850, issn 0007-1048, 10 p.Article

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma : updated results of a randomized controlled trial. CommentaryDURIE, Brian G. M; PALUMBO, Antonio; ZAMBELLO, Renato et al.Blood. 2008, Vol 112, Num 8, issn 0006-4971, 2998-2999, 3107-3114 [10 p.]Article

Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromesMUSTO, Pellegrino; LANZA, Francesco; GHIO, Riccardo et al.British journal of haematology. 2005, Vol 128, Num 2, pp 204-209, issn 0007-1048, 6 p.Article

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaCAVO, Michele; PANTANI, Lucia; NOZZOLI, Chiara et al.Blood. 2012, Vol 120, Num 1, pp 9-19, issn 0006-4971, 11 p.Article

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma : A report from the GIMEMA-Italian multiple myeloma networkPALUMBO, Antonio; FALCO, Patrizia; GAY, Francesca et al.Journal of clinical oncology. 2007, Vol 25, Num 28, pp 4459-4465, issn 0732-183X, 7 p.Article

Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromesMUSTO, Pellegrino; FALCONE, Antonietta; SANPAOLO, Grazia et al.British journal of haematology. 2003, Vol 122, Num 2, pp 269-271, issn 0007-1048, 3 p.Article

Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin aloneMUSTO, Pellegrino; SANPAOLO, Grazia; D'ARENA, Giovanni et al.Haematologica (Roma). 2001, Vol 86, Num 1, pp 44-51, issn 0390-6078Article

Efficacy and safety of once-weekly bortezomib in multiple myeloma patientsBRINGHEN, Sara; LAROCCA, Alessandra; GUGLIELMELLI, Tommasina et al.Blood. 2010, Vol 116, Num 23, pp 4745-4753, issn 0006-4971, 9 p.Article

Melphalan 200 mg/m2 versus melphalan 100 mg/m2 in newly diagnosed myeloma patients: a prospective, multicenter phase 3 studyPALUMBO, Antonio; BRINGHEN, Sara; LEVI, Anna et al.Blood. 2010, Vol 115, Num 10, pp 1873-1879, issn 0006-4971, 7 p.Article

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled TrialPALUMBO, Antonio; BRINGHEN, Sara; BENEVOLO, Giulia et al.Journal of clinical oncology. 2010, Vol 28, Num 34, pp 5101-5109, issn 0732-183X, 9 p.Article

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved SurvivalPALUMBO, Antonio; BRINGHEN, Sara; GRASSO, Mariella et al.Journal of clinical oncology. 2014, Vol 32, Num 7, pp 634-640, issn 0732-183X, 7 p.Article

  • Page / 1